Clinical Trial Update: Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Klimadynon to conjugated estrogens for menopausal complaints has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Conjugated Estrogens (ESTROGENS, CONJUGATED)
• Klimadynon

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Menopause | Phase 3 | Status: COMPLETED